Home > Specialties > Cement, Otologic

Cement, Otologic

Definition : Cement that is a glass-ionomeric, hydrophilic, osteoconductive, and biocompatible material used in otology. It comprises cement powder and liquid ingredients (such as autologous blood and antibiotics). It is intended for otologic procedures such as middle-ear reconstruction; to cement bone grafts, stapes prostheses, or cochlear implant electrodes; or to attach implantable hearing aid devices.

Entry Terms : "Otologic Cement" , "Cement"

UMDC code : 27902

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-3 of 3 Match(es).

ETEX Corp

Company Type: Parent

Established in 1989, ETEX Corporation develops, manufactures and commercializes calcium phosphate-based biomaterials for improved orthopedic clinical outcomes. A leader in bioresorbable bone substitute materials, ETEX focuses on expanding applications through combinations with cells, biologics, or therapeutic agents delivered in minimally invasive and easy to use systems.

Invotec International Inc

Company Type: Parent

Invotec International was founded in 1990 in Jacksonville, Florida. Over the last 19 years, Invotec has evolved into a world class supplier of Instruments, Optics, Implants and Supplies for Ear, Nose and Throat and Plastics and Cosmetic Surgery. A key part of Invotec's ongoing mission is providing a wide selection of superior quality products, priced for best value. The Rhinology Accessory Portfolio stands as Invotec's Global Flagship Business Line. The highest quality, advanced design and softness of the Breathe-Easy™ Septal/Airway Splint, joined with an expansive selection of Custom – Cut™ silicone & fluoroplastic splinting and sheeting, sets Invotec apart in the world Rhinology supply arena. Swiss Therapy™ Cold Therapy Mask and Sheeting have evolved into the benchmarks in PostOP Blepharoplasty, Rhinoplasty and Laser/IOL Skin Treatment Cooling Comfort accessories.

Valeant Pharmaceuticals International

Company Type: Parent

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops and markets prescription and nonprescription pharmaceutical products that make a meaningful difference in patients' lives. Valeant is focused on the dermatology and neurology therapeutic areas primarily in the United States, Canada, Mexico, Brazil, Central and Eastern Europe, Australia, South East Asia and South Africa.

1-3 of 3 Match(es).